These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2885639)

  • 1. Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges.
    Mistry CD; Mallick NP; Gokal R
    Lancet; 1987 Jul; 2(8552):178-82. PubMed ID: 2885639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can ultrafiltration occur with a hypo-osmolar solution in peritoneal dialysis?: The role for 'colloid' osmosis.
    Mistry CD; Gokal R
    Clin Sci (Lond); 1993 Oct; 85(4):495-500. PubMed ID: 8222517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal transport characteristics with glucose polymer based dialysate.
    Ho-dac-Pannekeet MM; Schouten N; Langendijk MJ; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1996 Sep; 50(3):979-86. PubMed ID: 8872974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
    Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
    Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a peritoneal dialysis solution containing polymer.
    Rubin J; Jones Q; Planch A; Bower J; Klein E
    Am J Med Sci; 1985 Jan; 289(1):12-6. PubMed ID: 3970061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal use of glucose polymer (icodextrin) in peritoneal dialysis.
    Mistry CD; Gokal R
    Perit Dial Int; 1996; 16 Suppl 1():S104-8. PubMed ID: 8728173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal fluid kinetics: comparison between polyglucose solution and albumin solution.
    Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
    Adv Perit Dial; 1999; 15():21-7. PubMed ID: 10682066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Threefold peritoneal test of osmotic conductance, ultrafiltration efficiency, and fluid absorption.
    Waniewski J; Paniagua R; Stachowska-Pietka J; Ventura MD; Ávila-Díaz M; Prado-Uribe C; Mora C; García-López E; Lindholm B
    Perit Dial Int; 2013; 33(4):419-25. PubMed ID: 23378471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term studies on the use of glycerol as an osmotic agent in continuous ambulatory peritoneal dialysis (CAPD).
    Heaton A; Ward MK; Johnston DG; Nicholson DV; Alberti KG; Kerr DN
    Clin Sci (Lond); 1984 Jul; 67(1):121-30. PubMed ID: 6734073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theoretical analysis of osmotic agents in peritoneal dialysis. What size is an ideal osmotic agent?
    Rippe B; Zakaria el-R ; Carlsson O
    Perit Dial Int; 1996; 16 Suppl 1():S97-103. PubMed ID: 8728172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple models for fluid transport during peritoneal dialysis.
    Waniewski J; Heimbürger O; Werynski A; Lindholm B
    Int J Artif Organs; 1996 Aug; 19(8):455-66. PubMed ID: 8841844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis.
    Mactier RA; Khanna R; Twardowski Z; Moore H; Nolph KD
    J Clin Invest; 1987 Nov; 80(5):1311-6. PubMed ID: 3680499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single daily overnight (12-h dwell) use of 7.5% glucose polymer (Mw 18700; Mn 7300) +0.35% glucose solution: a 3-month study.
    Mistry CD; Gokal R
    Nephrol Dial Transplant; 1993; 8(5):443-7. PubMed ID: 7688108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High peritoneal residual volume decreases the efficiency of peritoneal dialysis.
    Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
    Kidney Int; 1999 May; 55(5):2040-8. PubMed ID: 10231469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitution of a starch polymer for glucose in peritoneal dialysis.
    Rubin J; Jones Q; Planch A; Bower J; Klein E
    Nephron; 1985; 39(1):40-6. PubMed ID: 3969189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of glucose polymer (icodextrin) in peritoneal dialysis: an overview.
    Mistry CD; Gokal R
    Perit Dial Int; 1994; 14 Suppl 3():S158-61. PubMed ID: 7948266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrafiltration and solute kinetics using low sodium peritoneal dialysate.
    Leypoldt JK; Charney DI; Cheung AK; Naprestek CL; Akin BH; Shockley TR
    Kidney Int; 1995 Dec; 48(6):1959-66. PubMed ID: 8587258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
    Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
    Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of combined crystalloid and colloid osmosis to fluid and sodium management in peritoneal dialysis.
    Freida P; Wilkie M; Jenkins S; Dallas F; Issad B
    Kidney Int Suppl; 2008 Apr; (108):S102-11. PubMed ID: 18379532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE; Plosker GL
    Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.